INTERFERON-BASED CANCER TREATMENT METHOD, AND PHARMACEUTICAL COMBINATION

The present invention relates to the field of biomedicine. Disclosed herein is interferon-based method and pharmaceutical combination for treating cancer. In particular, the present invention relates to an interferon-based method for treating cancer, comprising i) intermittently administering an interferon-based therapeutic agent, and ii) administering an additional anticancer agent, preferably, Gemcitabine, to a subject, wherein said additional anti-cancer agent is administered after the first administration of said intermittent administration of an interferon-based therapeutic agent. The present invention also relates to a pharmaceutical combination for use in said method..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 29. Nov. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

ZHUANG LU [VerfasserIn]
ZHU PEIJUAN [VerfasserIn]
XIAO QINGJIANG [VerfasserIn]
CHU HONGRAN [VerfasserIn]
LIN CHONGYANG [VerfasserIn]
XIAO XIAOXUE [VerfasserIn]
XIA QIUJU [VerfasserIn]
WU HANZHOU [VerfasserIn]
LIAO XIAOJIN [VerfasserIn]
ZHOU WEIDONG [VerfasserIn]
SUN LI [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-11-29, Last update posted on www.tib.eu: 2024-04-02, Last updated: 2024-04-09

Patentnummer:

EP4282427

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA002869977